TAK
Takeda is a global biopharmaceutical company focused on discovering and developing medicines across multiple areas including oncology, immunology, hematology, vaccines, and rare diseases. With R&D-driven science and a patient-centric approach, the company aims to bring Better Health and a Brighter Future to people worldwide, with operations spanning its headquarters in Japan and presence across global markets.
No recent deals for this company.